| 12219796 |
Display substrate having a blocking dam provided with at least one groove and manufacturing method therefor, and display device |
Mingxing S. Li |
2025-02-04 |
|
| 11132951 |
Pixel circuit, pixel driving method and display device |
Yinglong Huang, Wenbao Gao |
2021-09-28 |
|
| 11127347 |
Pixel circuit, driving method thereof and display panel |
Yinglong Huang, Wenbao Gao |
2021-09-21 |
|
| 9428511 |
Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
Gregory D. Brown, Arun Kumar Gupta, William J. Pitts |
2016-08-30 |
|
| 9221826 |
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
Stephen T. Wrobleski, Jagabandhu Das, Lidia M. Doweyko, Junqing Guo, John Hynes +6 more |
2015-12-29 |
|
| 8987268 |
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
Stephen T. Wrobleski, Jagabandhu Das, Jingwu Duan, Junqing Guo, John Hynes +7 more |
2015-03-24 |
$102,355,000 |
| 8921368 |
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
Stephen T. Wrobleski, Gregory D. Brown, Lidia M. Doweyko, Jingwu Duan, Junqing Guo +8 more |
2014-12-30 |
$242,906,000 |
| 8222247 |
Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof |
Lidia M. Doweyko |
2012-07-17 |
$44,953,000 |
| 8198311 |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
James Sheppeck, John L. Gilmore, T. G. Murali Dhar, Hai-Yun Xiao, Jianmin Wang +1 more |
2012-06-12 |
$87,290,000 |
| 8106046 |
Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
— |
2012-01-31 |
$120,693,000 |
| 8034940 |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
David S. Weinstein, Ping Chen, T. G. Murali Dhar, Jingwu Duan, Hua Gong +2 more |
2011-10-11 |
$220,416,000 |
| 8013004 |
Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
T. G. Murali Dhar, Hai-Yun Xiao |
2011-09-06 |
$98,106,000 |
| 7968577 |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
Lidia M. Doweyko, Wayne Vaccaro, Tram N. Huynh, David R. Tortolani, T. G. Murali Dhar |
2011-06-28 |
$44,563,000 |
| 7642273 |
Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
T. G. Murali Dhar, Hai-Yun Xiao |
2010-01-05 |
$65,681,000 |
| 7544808 |
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
David S. Weinstein, John L. Gilmore, James Sheppeck, Soong-Hoon Kim, Wayne Vaccaro |
2009-06-09 |
$170,709,000 |
| 7411071 |
Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
Lidia M. Doweyko, Arthur M. P. Doweyko |
2008-08-12 |
$223,608,000 |
| 7361654 |
Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
James Sheppeck, T. G. Murali Dhar, Lidia M. Doweyko, John L. Gilmore, David S. Weinstein +2 more |
2008-04-22 |
$110,145,000 |
| 7326728 |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
— |
2008-02-05 |
$53,943,000 |
| 7317024 |
Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
— |
2008-01-08 |
$47,907,000 |
| 7273881 |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
— |
2007-09-25 |
$30,502,000 |
| 7253283 |
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
David S. Weinstein, John L. Gilmore, James Sheppeck, Soong-Hoon Kim, Wayne Vaccaro |
2007-08-07 |
$77,435,000 |
| 6995181 |
Modulators of the glucocorticoid receptor and method |
Wayne Vaccaro, Soong-Hoon Kim, Tram N. Huynh, David R. Tortolani, Kenneth J. Leavitt +4 more |
2006-02-07 |
$27,761,000 |
| 6964961 |
Thiophene derivatives useful as anticancer agents |
Michael Joseph Luzzio, Matthew Arnold Marx |
2005-11-15 |
$274,166,000 |
| 6844357 |
Substituted quinolin-2-one derivatives useful as antiproliferative agents |
— |
2005-01-18 |
$194,723,000 |
| 6777393 |
4″-substituted-9-deoxo-9a-aza-9a homoerythromycin a derivative |
Brian Bronk, Michael A. Letavic, Takushi Kaneko, Edward A. Glazer, Hengmiao Cheng |
2004-08-17 |
$181,200,000 |
